Miami

Running trials

• Active, not recruiting

  A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

  NCT07260877· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

  NCT07220629· Phase 2· Source

• Completed

  Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

  NCT07055516· Phase 2· Source

• Terminated

  A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease

  NCT06822517· Phase 1/2· Source

• Completed

  Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

  NCT06129409· Phase 1· Source

• Completed

  Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

  NCT04856085· Phase 2· Source